Goldberg Michael sold $2.1M of CDNA
Goldberg Michael sold 44,700 shares of CareDx, Inc. (CDNA) at $47.06 ($2.10M total) on 2026-08-04.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed open-market sale size, price, and post-transaction holdings. It may influence short-term sentiment but does not provide new operational or financial information about CareDx.
Market read
Traders may note insider selling as a minor sentiment input, but there is no accompanying fundamental catalyst in the text.
What to watch
The article does not state whether the director’s remaining holdings or future planned sales change, nor does it provide context like option exercises, tax events, or pre-scheduled trading beyond noting no 10b5-1 plan.
Background
The article is a SEC Form 4 insider transaction disclosure for CareDx, Inc. (CDNA).
Ticker impact
CareDx director Michael Goldberg filed a Form 4 selling 44,700 shares at $47.0581 on 2026-08-04, totaling about $2.10M.
Likely limited near-term impact; any effect would be sentiment-driven and small unless follow-on selling appears.
The filing is primary-source and time-stamped, but it does not include new company performance, guidance, or regulatory/contract developments. Insider sales are common and often non-informational, though the absence of a stated 10b5-1 plan can increase interpretive sensitivity.
Market effects
No sector-wide signal; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
The sale may be routine liquidity or diversification, especially since the filing does not allege misconduct or tie the sale to any new negative event.
Key entities
- issuerCareDx, Inc.
Subject of the Form 4 insider transaction disclosure (CDNA).
- insiderMichael Goldberg
Director who sold 44,700 shares in an open-market transaction.
- filingSEC Form 4
Primary-source insider transaction report filed on 2026-08-06.
